Cargando…

Efficacy of Neoadjuvant Chemotherapy plus Limb-Sparing Surgery for Osteosarcoma and Its Impact on Long-Term Quality of Life

PURPOSE: To assess the efficacy of neoadjuvant chemotherapy plus limb-sparing surgery for osteosarcoma and its impact on long-term quality of life. METHODS: Between August 2016 and December 2018, 90 patients with osteosarcoma treated in Nanchong Central Hospital were recruited and divided at a ratio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jing, Shixia, Ding, Fengling, Yuan, Yinghong, An, Jing, He, Qiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377866/ https://www.ncbi.nlm.nih.gov/pubmed/35978993 http://dx.doi.org/10.1155/2022/1693824

Ejemplares similares

Neoadjuvant chemotherapy combined with limb salvage surgery in patients with limb osteosarcoma of Enneking stage II: a retrospective study
por: Yuan, Guangke, et al.
Publicado: (2017)

Addition of Zoledronate to Chemotherapy in Patients with Osteosarcoma Treated with Limb-Sparing Surgery: A Phase III Clinical Trial
por: Li, Shenglong, et al.
Publicado: (2019)

Efficacy of Recombinant Human Endostatin plus Neoadjuvant Chemotherapy for Osteosarcoma and Its Influence on Serum VEGF and MMP-9 Levels
por: Sui, Wei, et al.
Publicado: (2023)

Marginal resection for osteosarcoma with effective neoadjuvant chemotherapy: long-term outcomes
por: Xu, Ming, et al.
Publicado: (2014)

Efficacy of frozen autograft treated with liquid nitrogen in limb-sparing surgery in feline scapular osteosarcoma: A case report
por: AKASAKA, Minori, et al.
Publicado: (2019)

A meta‐analysis comparing efficiency of limb‐salvage surgery vs amputation on patients with osteosarcoma treated with neoadjuvant chemotherapy
por: Abdelgawad, Mohamed A, et al.
Publicado: (2022)

The Plasma Concentration of D-Dimer is Associated with Neoadjuvant-Chemotherapy Efficacy and the Prognosis in Osteosarcoma
por: Huang, Yujing, et al.
Publicado: (2021)

Monitoring early responses to neoadjuvant chemotherapy and the factors affecting neoadjuvant chemotherapy responses in primary osteosarcoma
por: Yu, Hong, et al.
Publicado: (2023)

A rare case of locally advanced fibrosarcoma of diaphysal humerus managed successfully with limb-sparing procedures after neoadjuvant chemotherapy
por: El Mesbahi, Omar, et al.
Publicado: (2010)

Abstract 11. The Effect of Neoadjuvant Chemotherapy Compared to Adjuvant Chemotherapy in Nipple-Sparing Mastectomy
por: Frey, Jordan D., et al.
Publicado: (2017)

Predictive value of DCE-MRI and IVIM-DWI in osteosarcoma patients with neoadjuvant chemotherapy
por: Xia, Xibin, et al.
Publicado: (2022)

Significance of circulating tumor cells in osteosarcoma patients treated by neoadjuvant chemotherapy and surgery
por: Wu, Zhen-Jie, et al.
Publicado: (2018)

The number of osteoclasts in a biopsy specimen can predict the efficacy of neoadjuvant chemotherapy for primary osteosarcoma
por: Araki, Yoshihiro, et al.
Publicado: (2021)

Methotrexate Free Chemotherapy and Limb Salvage Surgery for Paediatric Osteosarcoma in India
por: Sukumaran, Reghu Kesavapillai, et al.
Publicado: (2018)

Bone transport using the Ilizarov method for osteosarcoma patients with tumor resection and neoadjuvant chemotherapy
por: Wang, Wei, et al.
Publicado: (2019)

Neoadjuvant chemotherapy followed by fertility-sparing surgery for women with stage IB1 cervical cancer
por: Wang, Dan, et al.
Publicado: (2013)

Limb-salvage surgery offers better five-year survival rate than amputation in patients with limb osteosarcoma treated with neoadjuvant chemotherapy. A systematic review and meta-analysis
por: Papakonstantinou, Evgenia, et al.
Publicado: (2020)

Effects of the potassium‐sparing diuretic amiloride on chemotherapy response in canine osteosarcoma cells
por: Poon, Andrew C., et al.
Publicado: (2018)

Reprograming the tumor immunologic microenvironment using neoadjuvant chemotherapy in osteosarcoma
por: Deng, Chuangzhong, et al.
Publicado: (2020)

Analysis of prognostic factors and histopathological response to neoadjuvant chemotherapy in osteosarcoma
por: Erdoğan, Furkan, et al.
Publicado: (2023)

Factors Predicting Locoregional Recurrence After Neoadjuvant Chemotherapy and Nipple-Sparing/Skin-Sparing Mastectomy With Immediate Breast Reconstruction
por: Wu, Zhen-Yu, et al.
Publicado: (2021)

Efficacy and prognostic factors of neoadjuvant chemotherapy for triple-negative breast cancer
por: Ding, Feng, et al.
Publicado: (2022)

Neoadjuvant immune checkpoint inhibitor plus chemotherapy in rare tracheal tumors
por: Jiang, Ben‐Yuan, et al.
Publicado: (2021)

Clinical Efficacy of Acupuncture on Neoadjuvant Chemotherapy with Capecitabine plus Paclitaxel and Radiotherapy in Progressive Gastric Cancer
por: Miao, Xiaomei, et al.
Publicado: (2022)

Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy
por: Robl, Bernhard, et al.
Publicado: (2015)

Urodynamic outcomes after pelvic nerve-sparing radical hysterectomy with or without neoadjuvant chemotherapy
por: Tsunetoh, Satoshi, et al.
Publicado: (2019)

Oncological safety of nipple-sparing mastectomy after neoadjuvant chemotherapy: a systematic review
por: NISSEN, LEONARDO, et al.
Publicado: (2023)

Is There a Reliable Method to Predict the Limb Length Discrepancy after Chemotherapy and Limb Salvage Surgery in Children with Osteosarcoma?
por: Li, Yuan, et al.
Publicado: (2016)

The Safety and Efficacy of Neoadjuvant Camrelizumab Plus Chemotherapy in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma: A Retrospective Study
por: Yin, Guo-Qiang, et al.
Publicado: (2022)

Author Correction: The number of osteoclasts in a biopsy specimen can predict the efficacy of neoadjuvant chemotherapy for primary osteosarcoma
por: Araki, Yoshihiro, et al.
Publicado: (2021)

Machine Learning-Based Radiomics Nomogram With Dynamic Contrast-Enhanced MRI of the Osteosarcoma for Evaluation of Efficacy of Neoadjuvant Chemotherapy
por: Zhang, Lu, et al.
Publicado: (2021)

LONG-TERM RESULTS OF EXTREMITY SOFT TISSUE SARCOMAS LIMB-SPARING SURGERY AND RADIOTHERAPY
por: Dogan, Özlem Yetmen, et al.
Publicado: (2019)

Equal quality of life after limb-sparing or ablative surgery for lower extremity sarcomas
por: Zahlten-Hinguranage, A, et al.
Publicado: (2004)

Transition from Tumor Tissue to Bone Marrow in Patients with Appendicular Osteosarcoma after Neoadjuvant Chemotherapy
por: Deng, Zhi-Ping, et al.
Publicado: (2017)

Anasarca sparing one limb
por: Pande, Arunkumar R., et al.
Publicado: (2011)

Adjuvant Chemotherapy for Pathological Node-Positive Disease in Squamous Cell Carcinoma of the Esophagus after Neoadjuvant Chemoradiotherapy Plus Surgery
por: Lin, Jing-Wei, et al.
Publicado: (2022)

Enrichment of osteosarcoma stem cells by chemotherapy
por: Tang, Qing-Lian, et al.
Publicado: (2011)

Limb sparing in a cat with a humeral osteosarcoma using a customised three-dimensional printed endoprosthesis
por: Malak, Anthony, et al.
Publicado: (2023)

Comparison of Neoadjuvant Immunotherapy Plus Chemotherapy versus Neoadjuvant Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: A Propensity Score Matching Study
por: Zhao, Junfeng, et al.
Publicado: (2023)

Fibrinogen–Albumin Ratio Index Exhibits Predictive Value of Neoadjuvant Chemotherapy in Osteosarcoma
por: Li, Zhendong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a5gktq024e2hv0ai4vmh630kah